Panos Zanos

75 Kallipoleos Avenue
Nicosia, 1678, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

From depression to bone health: Examining the skeletal effects of classical and rapid-acting antidepressants.

From depression to bone health: Examining the skeletal effects of classical and rapid-acting antidepressants.

Journal: The international journal of neuropsychopharmacology

Published: March 05, 2026

Justifying and reporting the use of stress protocols in pre-clinical experiments that use animals.

Justifying and reporting the use of stress protocols in pre-clinical experiments that use animals.

Journal: British journal of pharmacology

Published: December 05, 2025

Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapies.

Major depressive disorder: susceptibility, underlying mechanisms, and emerging therapies.

Journal: Trends in molecular medicine

Published: November 24, 2025

Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actions.

Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actions.

Journal: Communications medicine

Published: July 18, 2025

Linking misophonia and tinnitus: Common and divergent neurobiological mechanisms.

Linking misophonia and tinnitus: Common and divergent neurobiological mechanisms.

Journal: Neuroscience and biobehavioral reviews

Published: May 02, 2025

Estradiol, via estrogen receptor β signaling, mediates stress-susceptibility in the male brain.

Estradiol, via estrogen receptor β signaling, mediates stress-susceptibility in the male brain.

Journal: Molecular psychiatry

Published: February 07, 2025

Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer's Disease Pathogenesis-From Gut Microbiota and Viruses to Brain Biofilms.

Shattering the Amyloid Illusion: The Microbial Enigma of Alzheimer's Disease Pathogenesis-From Gut Microbiota and Viruses to Brain Biofilms.

Journal: Microorganisms

Published: December 11, 2024

(2R,6R)-hydroxynorketamine prevents opioid abstinence-related negative affect and stress-induced reinstatement in mice.

(2R,6R)-hydroxynorketamine prevents opioid abstinence-related negative affect and stress-induced reinstatement in mice.

Journal: British journal of pharmacology

Published: November 22, 2024

From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems Bioinformatics.

From Viral Infections to Alzheimer's Disease: Unveiling the Mechanistic Links Through Systems Bioinformatics.

Journal: The Journal of infectious diseases

Published: September 10, 2024

One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders.

One path, two solutions: Network-based analysis identifies targetable pathways for the treatment of comorbid type II diabetes and neuropsychiatric disorders.

Journal: Computational and structural biotechnology journal

Published: July 12, 2024

Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders.

Ketamine and Hydroxynorketamine as Novel Pharmacotherapies for the Treatment of Opioid Use Disorders.

Journal: Biological psychiatry

Published: July 10, 2024

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers.

Journal: Clinical pharmacology and therapeutics

Published: April 11, 2024

Showing 1-12 of 78

Last Updated: 09/26/2026